As of April 2026 Enliven Therapeutics has a market cap of A$3.36 Billion. This makes Enliven Therapeutics the world's 4433th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Apr 2nd, 2026 the market cap of Enliven Therapeutics was reported to be: